Comparison between patient-reported and clinician-observed symptoms in oncology

Cancer Nursing

Volumn 36, Issue 6, 2013, Pages

  Xiao, Canhua ^a   Polomano, Rosemary ^b   Bruner, Deborah Watkins ^a  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adverse drug reaction reporting systems; Humans; Neoplasms; Outcome assessment (healthcare) methods; Patients; Physicians; Symptoms; Treatment outcome

Indexed keywords

ARTICLE; BREAST CANCER; CANCER FATIGUE; CANCER PAIN; CANCER PATIENT; CLINICAL PRACTICE; DISEASE SEVERITY; DISTRESS SYNDROME; DOCTOR PATIENT RELATION; EMOTION; HEALTH STATUS; HUMAN; NAUSEA; ONCOLOGY; PATIENT ATTITUDE; PRIORITY JOURNAL; SYMPTOM; SYMPTOM ASSESSMENT; VOMITING;

ATTITUDE OF HEALTH PERSONNEL; HEALTH STATUS; HUMANS; ONCOLOGY NURSING; QUESTIONNAIRES; SELF REPORT; SYMPTOM ASSESSMENT;

EID: 84887112382     PISSN: 0162220X     EISSN: 15389804     Source Type: Journal    
DOI: 10.1097/NCC.0b013e318269040f     Document Type: Article

References (53)

1. Cancer Facts & Figures. Atlanta, GA: American Cancer Society; 2008.
2. Cam K, Akman Y, Cicekci B, Senel F, Erol A. Mode of administration of international prostate symptom score in patients with lower urinary tract symptoms: physician vs self. Prostate Cancer Prostatic Dis. 2004; 7(1): 41-41. (Pubitemid 38443530)
3. Werner A, Stenner C, Schuz J. Patient versus clinician symptom reporting: how accurate is the detection of distress in the oncologic after-care? Psychooncology. http://web.ebscohost.com/ehost/external?sid=f529-d38-0-89-40- 7- 907-dfddb7-a302-%40-essionmgr10&vid=2&hid=7. Accessed May 4, 2011.
4. Newell S, Sanson-Fisher RW, Girgis A, Bonaventura A. How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems?Data froma survey of five oncologists. Cancer. 1998; 83(8): 1640-1651. (Pubitemid 28465484)
5. Tan AS, Bourgoin A, Gray SW, Armstrong K, Hornik RC. How does patient-clinician information engagement influence self-reported cancerrelated problems?: Findings from a longitudinal analysis. Cancer. 2011; 117(11):2569-2576.
6. Takeuchi EE, Keding A, Awad N, et al. Impact of patient-reported outcomes in oncology: a longitudinal analysis of patient-physician communication. J Clin Oncol. 2011;29(21):2910-2917.
7. Kutner JS, Bryant LL, Beaty BL, Fairclough DL. Symptom distress and quality-of-life assessment at the end of life: the role of proxy response. J Pain Symptom Manage. 2006;32(4):300-310. (Pubitemid 44430133)
8. Sprangers MA, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol. 1992;45(7):743-760.
9. Acquadro C, Berzon R, Dubois D, et al. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health. 2003;6(5):522-531. (Pubitemid 37187713)
10. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79.
11. Basch E, Iasonos A, McDonough T, et al. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol. 2006;7(11):903-909. (Pubitemid 44615944)
12. Petersen, Larsen H, Pedersen L, Sonne N, Groenvold M. Assessing healthrelated quality of life in palliative care: comparing patient and physician assessments. Eur J Cancer. 2006;42(8):1159-1166.
13. Lenz ER, Pugh LC, Milligan RA, Gift A, Suppe F. Themiddle-range theory of unpleasant symptoms: an update. ANS Adv Nurs Sci. 1997;19(3):14-27. (Pubitemid 127460653)
14. Bernhard J, Maibach R, Thurlimann B, Sessa C, Aapro MS, Swiss Group for Clinical Cancer R. Patients' estimation of overall treatment burden: why not ask the obvious? J Clin Oncol. 2002;20(1):65-72. (Pubitemid 34032597)
15. Cirillo M, Venturini M, Ciccarelli L, Coati F, Bortolami O, Verlato G. Clinician versus nurse symptom reporting using the National Cancer InstituteYCommon Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire. Ann Oncol. 2009;20(12):1929-1935.
16. Jarernsiripornkul N, Krska J, Capps PA, Richards RM, Lee A. Patient reporting of potential adverse drug reactions: a methodological study. Br J Clin Pharmacol. 2002;53(3):318-325. (Pubitemid 34226975)
17. Litwin MS, Lubeck DP, Henning JM, Carroll PR. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database. J Urol. 1998;159(6):1988-1992. (Pubitemid 29190741)
18. Vistad I, Cvancarova M, Fossa SD, Kristensen GB. Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians' assessments agree with those of their patients? Int J Radiat Oncol Biol Physics. 2008;71(5):1335-1342.
19. ErazoValle A,Wisniewski T, Figueroa Vadillo JI, Burke TA,MartinezCorona R. Incidence of chemotherapy-induced nausea and vomiting in Mexico: healthcare provider predictions versus observed. Curr Med Res Opin. 2006; 22(12):2403-2410. (Pubitemid 46048355)
20. Glimelius B, Hoffman K,OlafsdottirM, Pahlman L, Sjoden PO,Wennberg A. Quality of life during cytostatic therapy for advanced symptomatic colorectal carcinoma: a randomized comparison of two regimens. Eur J Cancer Clin Oncol. 1989;25(5):829-835. (Pubitemid 19164327)
21. Grunberg SM,Deuson RR, Mavros P, et al. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics. Cancer. 2004;100(10):2261-2268. (Pubitemid 38580348)
22. Liau CT, Chu NM, Liu HE, Deuson R, Lien J, Chen JS. Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs. patients' reported outcomes. Support Care Cancer. 2005; 13(5):277-286. (Pubitemid 40674832)
23. Groenvold M, Klee MC, Sprangers MA, Aaronson NK. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol. 1997;50(4):441-450. (Pubitemid 27223274)
24. Fortner B, Baldwin S, Schwartzberg L, Houts AC. Validation of the Cancer Care Monitor items for physical symptoms and treatment side effects using expert oncology nurse evaluation. J Pain Symptom Manage. 2006;31(3): 207-214.
25. Atkinson TM, Li Y, Coffey CW, et al. Reliability of adverse symptom event reporting by clinicians. Qual Life Res. http://www.springerlink.com/content/x1- 7784307148-5-/fulltext.pdf. Accessed October 8, 2011.
26. Jensen K, Bonde Jensen A, Grau C. The relationship between observerbased toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC Quality of Life Questionnaires. Radiother Oncol. 2006; 78(3): 298-305.
27. Nekolaichuk CL, Bruera E, Spachynski K, MacEachern T, Hanson J, Maguire TO. A comparison of patient and proxy symptom assessments in advanced cancer patients. Palliat Med. 1999;13(4):311-323. (Pubitemid 29378209)
28. Stephens RJ, Hopwood P, Girling DJ, Machin D. Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings? Qual Life Res. 1997;6(3): 225-236. (Pubitemid 27293869)
29. Stout R, Barber P, Burt P, et al. Clinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs. external beam radiotherapy in the palliative treatment of inoperable non-small cell lung cancer. Radiother Oncol. 2000; 56(3):323-327.
30. Watkins-Bruner D, Scott C, Lawton C, et al. RTOG's first quality of life studyYRTOG 90-20: a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer. Int J Radiat Oncol Biol Physics. 1995;33(4):901-906.
31. Stiff PJ, Emmanouilides C, Bensinger WI, et al. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting. J Clin Oncol. 2006;24(33):5186-5193. (Pubitemid 46646481)
32. LuomaML, Hakamies-Blomqvist L, Sjostrom J, et al. Physical performance, toxicity, and quality of life as assessed by the physician and the patient. Acta Oncol. 2002;41(1):44-49. (Pubitemid 34293358)
33. McDonald MV, Passik SD, Dugan W, Rosenfeld B, Theobald DE, Edgerton S. Nurses' recognition of depression in their patients with cancer. Oncol Nurs Forum. 1999;26(3):593-599.
34. Oi-Ling K, Man-Wah DT, Kam-Hung DN. Symptom distress as rated by advanced cancer patients, caregivers and physicians in the last week of life. Palliat Med. 2005;19(3):228-233. (Pubitemid 40668082)
35. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer. 2004;4(4): 277-284. (Pubitemid 38525283)
36. Basch E, Jia X, Heller G, et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst. 2009;101(23):1624-1632.
37. D'Antonio LL, Long SA, Zimmerman GJ, Peterman AH, Petti GH, Chonkich GD. Relationship between quality of life and depression in patients with head and neck cancer. Laryngoscope. 1998;108(6):806-811. (Pubitemid 28299895)
38. Horton R. Differences in assessment of symptoms and quality of life between patients with advanced cancer and their specialist palliative care nurses in a home care setting. Palliat Med. 2002;16(6):488-494. (Pubitemid 35386006)
39. Nekolaichuk CL, Maguire TO, SuarezAlmazor M, Rogers WT, Bruera E. Assessing the reliability of patient, nurse, and family caregiver symptom ratings in hospitalized advanced cancer patients. J Clin Oncol. 1999; 17(11):3621-3630. (Pubitemid 29517935)
40. Quinten C, Maringwa J, Gotay CC, et al. Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst. 2011;103(24):1851-1858.
41. Greer J, Halgin R. Predictors of physician-patient agreement on symptom etiology in primary care. Psychosom Med. 2006;68(2):277-282. (Pubitemid 43740132)
42. Galer BS, Schwartz L, Turner JA. Do patient and physician expectations predict response to pain-relieving procedures? Clin J Pain. 1997;13(4): 348-351. (Pubitemid 28028100)
43. Golomb BA, McGraw JJ, Evans MA, Dimsdale JE. Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. Drug Saf. 2007;30(8):669-675. (Pubitemid 47295826)
44. Sarna L, Swann S, Langer C, et al. Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced nonYsmall-cell lung cancer: an analysis of RTOG 9801. Int J Radiat Oncol Biol Physics. 2008;72(5):1378-1384.
45. Mulders M, Vingerhoets A, Breed W. The impact of cancer and chemotherapy: perceptual similarities and differences between cancer patients, nurses and physicians. Eur J Oncol Nurs. 2008;12(2):97-102.
46. Heaven CM, Maguire P. Disclosure of concerns by hospice patients and their identification by nurses. Palliat Med. 1997;11(4):283-290. (Pubitemid 27373030)
47. Guthrie B, Inkster M, Fahey T. Tackling therapeutic inertia: role of treatment data in quality indicators. Br Med J. 2007;335(7619): 542-544. (Pubitemid 47477684)
48. Downie FP, Mar Fan HG, HouedeTchen N, Yi Q, Tannock IF. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Psychooncology. 2006;15(10):921-930. (Pubitemid 44612891)
49. Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J Clin Oncol. 2004;22(17):3485-3490. (Pubitemid 41103654)
50. Jensen K, Lambertsen K, Torkov P, Dahl M, Jensen AB, Grau C. Patient assessed symptoms are poor predictors of objective findings. Results from a cross sectional study in patients treated with radiotherapy for pharyngeal cancer. Acta Oncol. 2007;46(8):1159-1168. (Pubitemid 350058889)
51. Kwok HC, Morton RP, Chaplin JM, McIvor NP, Sillars HA. Quality of life after parotid and temporal bone surgery for cancer. Laryngoscope. 2002;112(5):820-833. (Pubitemid 34477611)
52. Wei JT, Montie JE. Comparison of patients' and physicians' ratings of urinary incontinence following radical prostatectomy. Semin Urol Oncol. 2000;18(1):76-80. (Pubitemid 30127591)
53. Basch E, Somerfield MR, Partridge A, Schnipper L, Lyman GH. Commentary: should cost and comparative value of treatments be considered in clinical practice guidelines? J Oncol Pract. 2011;7(6):398-401.